DOCSLIB.ORG

Argonautes in Extracellular Vesicles: Artifact Or Selected Cargo?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Argonautes in Extracellular Vesicles: Artifact Or Selected Cargo? Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Argonautes in extracellular vesicles: artifact or selected cargo? Alissa M. Weaver1,2, # and James G. Patton1,3,4 1. Department of Cell and Developmental Biology, Vanderbilt University School of Medicine 2. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center 3. Department of Biological Sciences, Vanderbilt University 4. Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center 5. # Correspondence to Alissa M. Weaver, 771 Preston Research Building, Vanderbilt University School of Medicine, Nashville, TN 37212 USA. Email: [email protected] Phone: 1-615-936-3529 Running Title: Argonautes as EV cargoes Abbreviations: Ago: Argonaute, EV: extracellular vesicle, miRNA: microRNA, RBP: RNA- binding protein, RISC: RNA-induced silencing complex, TRBP: transactivation response RNA- binding protein, WAGO: worm Argonaute Conflict of Interest Declaration: The authors have no financial conflicts of interest. We have published manuscripts in the area discussed in this “Controversy and Consensus”, which we have referenced. 1 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Argonaute-2 (Ago2) is a key component of the RNA-induced silencing complex (RISC) that mediates downregulation of mRNA by microRNAs. Its presence in extracellular vesicles (EVs) has been postulated to be important for the activity of EV-carried miRNA in modulating gene expression in recipient cells. However, whether it is in fact contained within EVs or is instead an extravesicular contaminant is controversial. In this opinion piece, we argue that the ability to detect Ago2 in EVs is a result of multiple factors, including cell source, cell signaling control of Ago2 trafficking to EVs, experimental conditions, and detection methods. 2 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Introduction Extracellular RNA comes in many forms, including cargo within extracellular vesicles (EVs) and non-vesicular RNA associated with RNA-binding proteins (RBPs) or lipoproteins. EV-carried microRNA (miRNA) has been of particular interest due to its potential to be transmitted to recipient cells and downregulate target mRNAs. As mRNA silencing and degradation is thought to require Argonaute-2 (Ago2), a key member of the RNA-induced silencing complex (RISC), whether Ago2-miRNA complexes are present in EVs has been of great interest to the field. One possibility is that miRNAs must be bound to Ago2 to efficiently assemble into functional RISCs for downregulation of mRNA targets in recipient cells. However, Ago2 has been variably reported by diverse investigators to be either inside or outside of EVs (1-9), leading to confusion as to whether Ago2-RNA complexes are transmitted via EVs. The location of Ago2-miRNA complexes to the inside of EVs has functional significance, as fusion of EVs with recipient cell membranes should deliver internal vesicle cargoes to the cytoplasm. By contrast, it is unclear how non-vesicular Ago-RNA complexes could access the cytoplasm of recipient cells to regulate gene expression. In this perspective, we argue that the ability to detect Ago2 in EVs is a result of multiple factors, including biological context, experimental conditions, and detection methods. A major confounding factor is the presence of large amounts of non-vesicular Ago2 and growth factors in serum, which is commonly used during cell culture. Role of EVs in transfer of RNA to recipient cells EVs are small lipid enclosed vesicles that are released from cells and carry diverse protein, lipid, and nucleic acid cargoes. They promote cellular communication in both an autocrine and paracrine fashion by multiple mechanisms, including direct induction of recipient cell signaling by ligand-receptor interactions and delivery of cargoes such as RNAs to the cytoplasm of recipient cells. Formation of EVs from endosomal membranes or the plasma membrane leads to an EV topology such that cytoplasmic cargoes such as RNAs are included inside EVs. Given this topology, EV-mediated delivery of RNAs to the cytoplasm of recipient cells should require fusion of EVs with recipient cell plasma membrane or endosomal membranes. It is not clear how RNA that is associated with the outside of EVs would be able to directly affect gene expression via miRNA-RISC-mRNA mechanisms, although such RNAs might be able to activate Toll-like receptors that are located on the inside of endosomes to induce signaling responses. Background on Argonautes and the RISC complex The RNA-induced silencing complex (RISC) is a multiprotein complex that binds miRNAs or other siRNAs and induces downregulation of complementary strands of RNA. A key component of this complex in mammalian cells is Ago2, which of all the Argonautes uniquely has RNA slicing activity. Dicer and transactivation response RNA-binding protein (TRBP) are two other components of the RISC loading complex that respectively process pre-miRNAs to their mature form and recruit Ago2 so that it can recognize target RNAs for silencing. Since miRNAs are present in EVs and have been shown to downregulate complementary mRNAs in recipient cells, the role of Ago2 in carrying miRNAs into EVs and mediating their biological effects has been of great interest to the field. Of note, the entire RISC loading complex was reported to be present in EVs and to mediate miRNA maturation (6). However, Ago2-RNA complexes are also present in body fluids in a non-vesicular form that appears to greatly exceed the amount contained within EVs (1,8). The origin of the non-vesicular form is unknown but has been postulated to derive from dead cells. We posit that Ago2-RNA complexes are present in both forms, but that the relative quantities and ability to detect them depend on multiple factors that we discuss below. 3 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 29, 2019; DOI: 10.1158/0008-5472.CAN-19-2782 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Regulation of Ago2 sorting by biological context – The molecular cargoes of EVs are selected by an active process, which is subject to regulation by the signaling and metabolic state of the cell. Cellular levels and subcellular distribution of proteins are also likely to contribute to determining the molecular content of EVs. Jeppesen et al. recently used high resolution density gradients to separate a crude small EV pellet into non-vesicular and vesicular fractions (3). Using Western blot analysis, they found that Argonautes, including Ago2, were present in both the vesicular and non-vesicular fractions of Gli36 glioblastoma EVs but only in the non-vesicular fractions of DKO1 or MDA-MB-231 EVs. As both DKO1 and MDA-MB-231 cells carry KRAS mutations, these findings are consistent with our previous finding that KRAS-MEK-ERK signaling greatly downregulates association of Ago2 with multivesicular bodies and reduces subsequent incorporation into exosome-type small EVs (5). Downregulation of Ago2 sorting to exosomes occurs both via growth factor-induced KRAS activation and through oncogenic mutations (5). Notably, most studies that have reported that Ago2 is not in EVs used KRAS- mutated cancer cells and/or growth factor-containing serum in their medium (3,7,9). In contrast to signal-mediated downregulation of Ago export, several pathogens appear to upregulate Ago2 trafficking into EVs. Thus, malarial infection of primary red blood cells or viral infection of Huh7.5 liver carcinoma cells have been shown to enhance Ago2 and miRNA trafficking into EVs (2,4). In addition, a related “worm” Argonaute protein (WAGO) was recently described to be transported into the EVs of parasitic worms in association with novel siRNAs (10). In some of those cases, the EV-associated Ago-RNA complexes were shown to contribute to pathogen infections (2,4). Effects of experimental conditions on Ago2 sorting and detection – Many experimental analyses of EVs are performed after purifying EVs from cultured cells. The metabolic and signaling state of those cultured cells can greatly affect the composition and extent of EV secretion. Serum is a typical cell culture additive that contains large amounts of growth factors, that would be likely to downregulate Ago2 trafficking into exosomes (5). In addition, serum contains a very large amount of non-vesicular Ago2 (1,8) which may contaminate crude EV pellets. The high signal from this non-EV-contained Ago2 may further decrease the ability to detect lower amounts of EV-contained Ago2 in density gradient fractions by Western blots, since exposure times are often determined by the bands with the highest signal. In addition to serum, the confluency of cells in 2D tissue culture can alter the composition (7) and extent of EV secretion, as would 3D culture methods. Role of purification and analysis methods in detection of non-vesicular and vesicular Ago2 – An argument against Ago2 being a specific cargo of EVs is that it could be a contaminant of EV preparations prepared by ultracentrifugation of conditioned medium at 100,000xg. Density gradient centrifugation is one method that has been widely used to separate vesicular from nonvesicular components. Using such methods, Ago2 has been identified in both the vesicular and nonvesicular fractions by Western blot analysis (3-5,7,9).
Load more

Recommended publications
  • Not Dicer but Argonaute Is Required for a Microrna Production
    Cell Research (2010) 20:735-737. npg © 2010 IBCB, SIBS, CAS All rights reserved 1001-0602/10 $ 32.00 RESEARCH HIGHLIGHT www.nature.com/cr A new twist in the microRNA pathway: Not Dicer but Argonaute is required for a microRNA production Gabriel D Bossé1, Martin J Simard1 1Laval University Cancer Research Centre, Hôtel-Dieu de Québec (CHUQ), Quebec City, Québec G1R 2J6, Canada Cell Research (2010) 20:735-737. doi:10.1038/cr.2010.83; published online 15 June 2010 Found in all metazoans, microRNAs A Canonical pathway B Ago2-dependent pathway or miRNAs are small non-coding RNA Nucleus Cytoplasm Nucleus Cytoplasm of ~22 nucleotides in length that com- Exp.5 Exp.5 pletely reshaped our understanding of gene regulation. This new class of gene pre-miR-451 regulator is mostly transcribed by the pre-miRNA RNA polymerase II producing a long stem-loop structure, called primary- or Ago2 pri-miRNA, that will first be processed Ago2 Dicer in the cell nucleus by a multiprotein TRBP complex called microprocessor to gen- erate a shorter RNA structure called Ago2 RISC precursor- or pre-miRNA. The precisely Ago2 RISC processed pre-miRNA will next be ex- ported into the cytoplasm by Exportin 5 and loaded onto another processing machine containing the ribonuclease III enzyme Dicer, an Argonaute protein Ago2 Ago2 and other accessory cellular factors mRNA mRNA (Figure 1A; [1]). Dicer will mediate the Translation inhibition Translation inhibition cleavage of the pre-miRNA to form the mature miRNA that will then be bound Figure 1 (A) Canonical microRNA biogenesis. In mammals, the pre-miRNA is by the Argonaute protein to form, most loaded onto a multiprotein complex consisting minimally of Dicer, Tar RNA Bind- likely with other cellular factors, the ef- ing Protein (TRBP) and Ago2.
    [Show full text]
  • The Argonaute Family: Tentacles That Reach Into Rnai, Developmental Control, Stem Cell Maintenance, and Tumorigenesis
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis Michelle A. Carmell,1,2,3 Zhenyu Xuan,1,3 Michael Q. Zhang,1 and Gregory J. Hannon1,4 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 2Program in Genetics, State University of New York at Stony Brook, Stony Brook, New York 11794, USA RNA interference (RNAi) is an evolutionarily conserved The Argonaute family process through which double-stranded RNA (dsRNA) Argonaute proteins make up a highly conserved family induces the silencing of cognate genes (for review, see whose members have been implicated in RNAi and re- Bernstein et al. 2001b; Carthew 2001). Sources of dsRNA lated phenomena in several organisms. In addition to silencing triggers include experimentally introduced roles in RNAi-like mechanisms, Argonaute proteins in- dsRNAs, RNA viruses, transposons, and RNAs tran- fluence development, and at least a subset are involved scribed from complex transgene arrays (for review, see in stem cell fate determination. Argonaute proteins are Hammond et al. 2001b). Short hairpin sequences en- ∼100-kD highly basic proteins that contain two common coded in the genome also appear to enter the RNAi path- domains, namely PAZ and PIWI domains (Cerutti et al. way and function to regulate the expression of endog- 2000). The PAZ domain, consisting of 130 amino acids, enous, protein-coding genes (Grishok et al. 2001; has been identified in Argonaute proteins and in Dicer Hutvagner et al. 2001; Ketting et al.
    [Show full text]
  • Argonaute Proteins at a Glance Christine Ender and Gunter Meister
    Cell Science at a Glance 1819 Argonaute proteins at a RNAs) – ncRNAs that are characteristically Biogenesis of miRNAs and siRNAs ~20-35 nucleotides long – are required for miRNAs glance the regulation of gene expression in many Generally, miRNAs are transcribed by RNA different organisms. Most small RNA species polymerase II or III to form stem-loop-structured Christine Ender1 and Gunter fall into one of the following three classes: primary miRNA transcripts (pri-miRNAs). pri- Meister1,2,* microRNAs (miRNAs), short-interfering RNAs miRNAs are processed in the nucleus by the 1 Center for Integrated Protein Science Munich (siRNAs) and Piwi-interacting RNAs (piRNAs) microprocessor complex, which contains (CIPSM), Laboratory of RNA Biology, Max-Planck- Institute of Biochemistry, Am Klopferspitz 18, 82152 (Carthew and Sontheimer, 2009). Although the RNAse III enzyme Drosha and its DiGeorge Martinsried, Germany different small RNA classes have different syndrome critical region gene 8 (DGCR8) 2University of Regensburg, Universitätsstraße 31, 93053 Regensburg, Germany bio genesis pathways and exert different cofactor. The transcripts are cleaved at the stem *Author for correspondence functions, all of them must associate with a of the hairpin to produce a stem-loop- ([email protected]) member of the Argonaute protein family for structured miRNA precursor (pre-miRNA) of Journal of Cell Science 123, 1819-1823 activity. This article and its accompanying ~70 nucleotides. After this first processing step, © 2010. Published by The Company of Biologists Ltd poster provide an overview of the different pre-miRNAs are exported into the cytoplasm by doi:10.1242/jcs.055210 classes of small RNAs and the manner in which exportin-5, where they are further processed they interact with Argonaute protein family by the RNAse III enzyme Dicer and its TRBP Although a large portion of the human genome members during small-RNA-guided gene (HIV transactivating response RNA-binding is actively transcribed into RNA, less than 2% silencing.
    [Show full text]
  • Mutual Regulation of RNA Silencing and the IFN Response As an Antiviral Defense System in Mammalian Cells
    International Journal of Molecular Sciences Review Mutual Regulation of RNA Silencing and the IFN Response as an Antiviral Defense System in Mammalian Cells Tomoko Takahashi 1,2,* and Kumiko Ui-Tei 1,3,* 1 Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan 2 Department of Biochemistry and Molecular Biology, Graduate School of Science and Engineering, Saitama University, Saitama 338-8570, Japan 3 Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan * Correspondence: [email protected] (T.T.); [email protected] (K.U.-T.); Tel.: +81-48-858-3404 (T.T.); +81-3-5841-3044 (K.U.-T.) Received: 23 December 2019; Accepted: 15 February 2020; Published: 17 February 2020 Abstract: RNA silencing is a posttranscriptional gene silencing mechanism directed by endogenous small non-coding RNAs called microRNAs (miRNAs). By contrast, the type-I interferon (IFN) response is an innate immune response induced by exogenous RNAs, such as viral RNAs. Endogenous and exogenous RNAs have typical structural features and are recognized accurately by specific RNA-binding proteins in each pathway. In mammalian cells, both RNA silencing and the IFN response are induced by double-stranded RNAs (dsRNAs) in the cytoplasm, but have long been considered two independent pathways. However, recent reports have shed light on crosstalk between the two pathways, which are mutually regulated by protein–protein interactions triggered by viral infection. This review provides brief overviews of RNA silencing and the IFN response and an outline of the molecular mechanism of their crosstalk and its biological implications.
    [Show full text]
  • Trna-Derived Short Non-Coding RNA As Interacting Partners of Argonaute Proteins
    Thomas Jefferson University Jefferson Digital Commons Computational Medicine Center Faculty Papers Computational Medicine Center 7-9-2015 tRNA-Derived Short Non-coding RNA as Interacting Partners of Argonaute Proteins. Megumi Shigematsu Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University Yohei Kirino, PhD Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University Follow this and additional works at: https://jdc.jefferson.edu/tjucompmedctrfp Part of the Other Medical Specialties Commons Let us know how access to this document benefits ouy Recommended Citation Shigematsu, Megumi and Kirino, PhD, Yohei, "tRNA-Derived Short Non-coding RNA as Interacting Partners of Argonaute Proteins." (2015). Computational Medicine Center Faculty Papers. Paper 7. https://jdc.jefferson.edu/tjucompmedctrfp/7 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Computational Medicine Center Faculty Papers by an authorized administrator of the Jefferson Digital Commons.
    [Show full text]
  • Assembly of a Dsrna Synthesizing Complex: RNA-DEPENDENT RNA POLYMERASE 2 Contacts the Largest Subunit of NUCLEAR RNA POLYMERASE IV
    Assembly of a dsRNA synthesizing complex: RNA-DEPENDENT RNA POLYMERASE 2 contacts the largest subunit of NUCLEAR RNA POLYMERASE IV Vibhor Mishraa,b, Jasleen Singhb, Feng Wanga,b, Yixiang Zhangc,d, Akihito Fukudomea,b, Jonathan C. Trinidadc,d, Yuichiro Takagie, and Craig S. Pikaarda,b,1 aHHMI, Indiana University, Bloomington, IN 47405; bDepartment of Biology and Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN 47405; cDepartment of Chemistry, Indiana University, Bloomington, IN 47405; dLaboratory for Biological Mass Spectrometry, Indiana University, Bloomington, IN 47405; and eDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202 Contributed by Craig S. Pikaard, February 17, 2021 (sent for review September 12, 2020; reviewed by Julie A. Law and R. Keith Slotkin) In plants, transcription of selfish genetic elements such as trans- refractive to promoter-dependent gene transcription, thus ac- posons and DNA viruses is suppressed by RNA-directed DNA meth- counting for gene silencing. ylation. This process is guided by 24-nt short-interfering RNAs Using purified Pol IV, RDR2, and DCL3, we recently reca- (siRNAs) whose double-stranded precursors are synthesized by pitulated the siRNA biogenesis phase of the RNA-directed DNA DNA-dependent NUCLEAR RNA POLYMERASE IV (Pol IV) and methylation pathway in vitro (13). These experiments revealed RNA-DEPENDENT RNA POLYMERASE 2 (RDR2). Pol IV and RDR2 that Pol IV and RDR2 enzymatic activities are coupled, with Pol coimmunoprecipitate, and their activities are tightly coupled, yet IV’s distinctive termination mechanism facilitating the direct the basis for their association is unknown. Here, we show that an handoff, or channeling, of transcripts to RDR2 (24).
    [Show full text]
  • Biogenesis and Mechanism of Action of Small Non-Coding Rnas: Insights from the Point of View of Structural Biology
    Int. J. Mol. Sci. 2012, 13, 10268-10295; doi:10.3390/ijms130810268 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Biogenesis and Mechanism of Action of Small Non-Coding RNAs: Insights from the Point of View of Structural Biology Marina C. Costa 1, Ana Lúcia Leitão 2 and Francisco J. Enguita 1,* 1 Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, Lisboa 1649-028, Portugal; E-Mail: [email protected] 2 Departamento de Ciências e Tecnologia da Biomassa, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus da Caparica, Caparica 2829-516, Portugal; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +351-21-7999503; Fax: +351-21-7999412. Received: 30 May 2012; in revised form: 17 July 2012 / Accepted: 2 August 2012 / Published: 17 August 2012 Abstract: Non-coding RNAs are dominant in the genomic output of the higher organisms being not simply occasional transcripts with idiosyncratic functions, but constituting an extensive regulatory network. Among all the species of non-coding RNAs, small non-coding RNAs (miRNAs, siRNAs and piRNAs) have been shown to be in the core of the regulatory machinery of all the genomic output in eukaryotic cells. Small non-coding RNAs are produced by several pathways containing specialized enzymes that process RNA transcripts. The mechanism of action of these molecules is also ensured by a group of effector proteins that are commonly engaged within high molecular weight protein-RNA complexes.
    [Show full text]
  • Single-Molecule Imaging Reveals That Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides
    Article Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides Graphical Abstract Authors William E. Salomon, Samson M. Jolly, Melissa J. Moore, Phillip D. Zamore, Victor Serebrov Correspondence [email protected] (P.D.Z.), [email protected] (V.S.) In Brief Argonaute proteins reshape how oligonucleotides find, bind, and dissociate from complementary nucleic acid sequences. By re-writing the rules, Argonautes allow oligonucleotides to serve as specificity determinants with thermodynamic and kinetic properties more typical of RNA-binding proteins. Highlights d Argonaute changes the rate of target finding by pre-organizing a region of its guide d Seed pairing is required for rapid target finding and stable binding d AGO2 releases its cleaved products by destabilizing their interaction with the guide d RISC makes its guide behave more like an RNA-binding protein and less like free RNA Salomon et al., 2015, Cell 162, 84–95 July 2, 2015 ª2015 Elsevier Inc. http://dx.doi.org/10.1016/j.cell.2015.06.029 Article Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides William E. Salomon,1 Samson M. Jolly,1 Melissa J. Moore,1 Phillip D. Zamore,1,* and Victor Serebrov1,* 1RNA Therapeutics Institute, Howard Hughes Medical Institute, and Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA *Correspondence: [email protected] (P.D.Z.), [email protected] (V.S.) http://dx.doi.org/10.1016/j.cell.2015.06.029 SUMMARY proteins contain an additional N-terminal domain that prevents base pairing of the target to the guide beyond guide position Argonaute proteins repress gene expression and g16 (Kwak and Tomari, 2012; Faehnle et al., 2013; Hauptmann defend against foreign nucleic acids using short et al., 2013).
    [Show full text]
  • Biochemical Mechanisms of the RNA-Induced Silencing Complex
    Zain Paroo et al. npg Cell Research (2007) 17:187-194. npg187 © 2007 IBCB, SIBS, CAS All rights reserved 1001-0602/07 $ 30.00 REVIEW www.nature.com/cr Biochemical mechanisms of the RNA-induced silencing complex Zain Paroo1, Qinghua Liu1, Xiaodong Wang1, 2 1Department of Biochemistry, 2Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA In less than 10 years since its inception, RNA interference (RNAi) has had extraordinary impact on biomedical sci- ence. RNAi has been demonstrated to influence numerous biological and disease pathways. Development and adoption of RNAi technologies have been prolific ranging from basic loss-of-function tools, genome-wide screening libraries to pharmaceutical target validation and therapeutic development. However, understanding of the molecular mechanisms of RNAi is far from complete. The purpose of this brief review is to highlight key achievements in elucidating the bio- chemical mechanisms of the RNA-induced silencing complex and to outline major challenges for the field. Keywords: Argonaute, Dicer, dsRBP, RISC, RNA interference Cell Research (2007) 17:187-194. doi: 10.1038/sj.cr.7310148; published online 20 February 2007 Introduction from longer dsRNA-silencing triggers [3, 6]. The phenomenon of RNA-induced silencing was first Small-interfering RNA documented in plants by Jorgensen and co-workers [1]. The Tuschl and co-workers [7] hypothesized that these field of RNA interference (RNAi) was initiated from studies smaller RNA species directed the activity of the RISC com- conducted by Fire, Mello and co-workers [2], who induced plex. Indeed, chemically synthesized 21mer duplexes were silencing of endogenous and reporter genes in Caenorhab- found to trigger the cleavage of complementary mRNA ditis elegans following injection of long double-stranded in Drosophila extract [7].
    [Show full text]
  • NON-CODING Rnas
    NON-CODING RNAs Types Synthesis Functions Examples Cells Produce Different Categories of RNA Molecules Noncoding RNAs Are Also Synthesized and Processed in the Nucleus REGULATION OF GENE EXPRESSION BY NONCODING RNAs Small Noncoding RNA Transcripts Regulate Many Animal and Plant Genes Through RNA Interference Three classes of small noncoding RNAs work in this way— microRNAs (miRNAs), small interfering RNAs (siRNAs), and piwi-interacting RNAs (piRNAs) miRNAs Regulate mRNA Translation and Stability. Estimated Over 4000 different microRNAs (miRNAs) are produced from the human genome, and these appear to regulate at least one- third of all human protein-coding genes. RNA interference in eukaryotes. Single-stranded interfering RNAs are generated from double-stranded RNA. They locate target RNAs through base-pairing and, at this point, several fates are possible, as shown. There are several types of RNA interference; the way the double-stranded RNA is produced and processed and the ultimate fate of the target RNA depends on the particular system. miRNA processing and mechanism of action. The precursor miRNA, through complementarity between one part of its sequence and another, forms a double-stranded structure. This RNA is cropped while still in the nucleus and then exported to the cytosol, where it is further cleaved by the Dicer enzyme to form the miRNA proper. Argonaute, in conjunction with other components of RISC, initially associates with both strands of the miRNA and then cleaves and discards one of them. The other strand guides RISC to specific mRNAs through base-pairing. If the RNA–RNA match is extensive, as is commonly seen in plants, Argonaute cleaves the target mRNA, causing its rapid degradation.
    [Show full text]
  • Bacterial Argonaute Sets Sail
    RESEARCH HIGHLIGHTS NPG BACTERIAL PHYSIOLOGY Bacterial argonaute sets sail In eukaryotes, argonaute proteins RNAs (diRNAs)) highlighted a strong To investigate the ability of the have important roles in small RNA- bias towards RNAs that had uridine argonaute protein to recognize for- mediated gene silencing. In a recent at the first position - a feature that eign nucleic acids, the authors used issue of Molecular Cell, Alexei Aravin is also present in many of the small Escherichia coli as a heterologous and colleagues demonstrate a role RNAs bound by eukaryotic argonaute host and found that expression of for a bacterial argonaute protein in proteins. The authors found that R. sphaeroides argonaute reduced the silencing foreign nucleic acids. the diRNAs mapped to the majority yield of the expression plasmid and Argonaute proteins have been of the sense transcripts from the resulted in the degradation of plas- identified in a range of bacteria and R. sphaeroides chromosomes and mid DNA. Comparative analysis of archaea. Although several crystallo­ endogenous plasmids, in addition the transcriptomes of wild-type and graphic structures have been made to showing a strong bias towards the argonaute-deficient R. sphaeroides available, and there has been a argonaute expression plasmid. There showed no difference in overall preliminary characterization of was no evidence of a preference for gene expression; however, when a the substrate-binding properties of a particular primary or secondary plasmid that expressed luciferase some bacterial argonaute proteins, structure in the RNA precursor. and LacI was introduced into the few experimental insights into their This suggests that diRNAs are either R.
    [Show full text]
  • Coexpression of Argonaute-2 Enhances RNA Interference Toward Perfect Match Binding Sites
    Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites Sven Diederichs*, Stephanie Jung, S. Michael Rothenberg, Gromoslaw A. Smolen, Barbara G. Mlody, and Daniel A. Haber† Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129-2020 Edited by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved April 11, 2008 (received for review January 25, 2008) RNAi is widely applied to inhibit expression of specific genes, but We recently demonstrated that Argonaute-2 (Ago2), the slicer it is limited by variable efficiency and specificity of empirically in the RNA Induced Silencing Complex (RISC), also functions designed siRNA or shRNA constructs. This complicates studies in endogenous miRNA biogenesis (11), in addition to its effector targeting individual genes and significantly impairs large-scale role in target mRNA cleavage. Here, we show that ectopic screens using genome-wide knockdown libraries. Here, we show coexpression of Ago2 has a profound effect on RNAi mediated that ectopic expression of the RISC slicer Argonaute-2 (Ago2, by siRNA, shRNA, or miRNA constructs, dramatically and eIF2C2) dramatically enhances RNAi specifically for mRNA targets selectively enhancing cleavage of perfectly matched RNA tar- with perfectly matched binding sites. This effect depends on its gets. This observation has immediate applications for the opti- endonuclease activity and is uncoupled from its regulation of mal design of RNAi strategies. microRNA expression.
    [Show full text]